Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01668771 · ClinicalTrials.gov registry record
Self-Affirmation and Response to Health Risk Information
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,116
- Enrollment target
NCT01668771: Completed study, sponsored by National Cancer Institute (NCI).
NCT01668771 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01668771 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,116 participants
- Enrollment target
Study Summary
Background: \- Self-affirmation is the process of reflecting on values that a person considers important. This process may encourage people to be more open to information about health risks. It may also encourage them to change their behaviors or lifestyle to decrease these health risks. Researchers want to look at the effect of self-affirmation on people s responses to new health risk information. Because recent studies have linked alcohol consumption to increased risk of breast cancer, the study will focus on alcohol s link to breast cancer. Objectives: \- To study how self-affirmation can change opinions following a message about a health risk. Eligibility: \- Women at least 18 years of age who drink at least two alcoholic beverages per week and/or at least three alcoholic beverages per sitting. Design: * Participants will be recruited through an online panel. The study will be conducted entirely online. * Participants will respond to two short studies. The first will ask about life events and how they make people feel. The second will look at how people respond to information about alcohol and breast cancer. * For the first study, participants will write a paragraph or two about an important event in their lives. They will answer questions about how that event made them feel. They will also write a paragraph about an important personal value. * For the second study, participants will read information about alcohol and breast cancer risk. They will then answer questions about this information. They will also answer questions about their beliefs about alcohol and breast cancer. * Participants will receive financial compensation for being in this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,116 participants |
| Start Date | 2012-08-11 |
| Est. Completion | 2013-05-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01668771
The ClinicalTrials.gov registry entry for NCT01668771 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01668771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01668771 about?
NCT01668771 is a clinical study titled "Self-Affirmation and Response to Health Risk Information". Background: \- Self-affirmation is the process of reflecting on values that a person considers important. This process may encourage people to be more open to information about health risks. It may also encourage them to change their behaviors or lifestyle to decrease these health risks. Researcher...
What is the current status of trial NCT01668771?
This trial is currently completed. The enrollment target is 1,116 participants. The study started on 2012-08-11. Estimated completion is 2013-05-13.
Who is sponsoring clinical trial NCT01668771?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.